Islet cells from human embryonic stem cells |
| This invention solves the problem of generating large populations of human islet cells by showing ... |
|
Neural thread protein gene expression and detection of alzheimer's disease |
| A need exists for a definitive diagnostic test which can be performed on individuals suspected of ... |
|
Method of detecting neurological disease or dysfunction |
| What is claimed is: 1. A method for detecting the presence of nPTP in a human subject, said method ... |
|
Metabolic pathway assay |
| This invention relates to an in vitro screening assay which identifies enzyme inhibitors. This ... |
|
MurC |
| What is claimed is: 1. An isolated polynucleotide segment comprising a first polynucleotide ... |
|
Murf gene and enzyme of Pseudomonas aeruginosa |
| Polynucleotides and polypeptides of Pseudomonas aeruginosa MurF, an enzyme involved in bacterial ... |
|
Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold |
| It is an object of the invention to provide a method of affecting nociception. It is an object of ... |
|
Liposomal transfection method |
| The object of the present invention is thus a method for transfecting a cell with a nucleic acid ... |
|
Antihelminthic anthraquinones and method of use thereof |
| OF THE INVENTION All patents, patent applications, government publications, government regulations,... |
|
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| The invention is directed to a new method of inducing viral mutagenesis which is useful in cell ... |
|
|
Biocompatible microcapsules
| Details |
Inventors: Hubbell, Jeffrey A.; Sawhney, Amarpreet S.;
Assignee: The Board of Regents, The University of Texas System (Austin, TX)
Primary Examiner: Page; Thurman K.
Assistant Examiner: Spear; James M.
Attorney, Agent or Firm: Lyon & Lyon
Biocompatible microcapsules useful for transplanting foreign material into an animal body, and the method of their production, are described, wherein the microcapsules contain an outermost layer of water soluble non-ionic polymers such as PEO to create resistance to cell adhesion on the surface of the microcapsules. |
|
DETAILED DESCRIPTION This invention for the first time demonstrates the use of water soluble non-ionic polymers such as PEO to create resistance to cell adhesion on the surface of microcapsules. This invention provides a method for transplanting foreign material into an animal body in a biocompatible manner. This is accomplished by providing microcapsules, biocompatible with the recipient animal, capable of encapsulating the foreign material to be transplanted into that animal. The normally charged outer layer of the microcapsules is covered by water soluble non-ionic polymers such as poly(ethylene oxide) (PEO) which act to shield the charge. These polymers are grafted to the polycationic polymers, such as poly-L-lysine (PLL) molecules used as at least one of the layers of the microcapsule, such that they create a non-ionic barrier between the outer layer of the microcapsule (made of essentially either polycationic polymers, such as PLL, or polyanionic polymers, such as alginate) and the recipient animal. The microcapsules then appear, from the outside, to have water-like surface properties, thus reducing the driving force for protein adsorption. Further, the surface, at the macromolecular level, is in a high degree of motion, further reducing protein adsorption and cell attachment. This invention further provides microcapsules, and a method for their production, in which the surface is more resistant to cell adhesion. As a result, overgrowth of the microcapsules by cells such as fibroblasts and macrophages is severely decreased or eliminated. Cells contained within the microcapsules are able to continue to receive nutrients and signal molecules, and produce whatever is their desired product. Any product present in the microcapsules, such as insulin produced by islet cells, can continue to diffuse out of the microcapsules and be available for utilization by the host animal. This invention also provides microcapsules, and a method for their production, which will not appreciably stimulate immune response or cytokine release by the recipient animal
|
| Related patents |
|
|
Composotions and methods for radiographic imaging
The present invention is a micellar iodine-containing block copolymer (MICBC) useful as a radiographic imaging agent. These micelle-forming block copolymers include a ...
|
|
|
Biocompatible microcapsules
This invention for the first time demonstrates the use of water soluble non-ionic polymers such as PEO to create resistance to cell adhesion on the surface of ...
|
|
|
Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell
What is claimed is: 1. A method for introducing a functional expression cassette into a cell, said method comprising: (a) providing a population of first and second ...
|
|
|
Phospholipid- or lipid-linked glycosaminoglycan and process for producing the same
What is claimed is: 1. A process for producing a phospholipid- or lipid-linked glycosaminoglycan represented by the following formula (VI), ##STR122## or a salt thereof, ...
|
|
|
Inhibition of excessive phospholipase A.sub.2 activity and/or production by non-antimicrobial tetracyclines
The present invention provides a method for treating mammals suffering from conditions associated with excess phospholipase A.sub.2 activity and/or production which ...
|
|
|
Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
OF THE INVENTION The invention describes methods and compositions for the treatment of rheumatoid arthritis and osteoarthritis and other conditions that manifest ...
|
|
|
A3AR agonists for the treatment of inflammatory arthritis
The invention is described in the following SUMMARY with reference to a therapeutic method for the treatment of inflammatory arthritis. It should be noted that in ...
|
|
|
Nucleic acids encoding high molecular weight major outer membrane protein of moraxella
The present invention is directed towards the provision of purified and isolated major outer membrane protein of Moraxella catarrhalis and other Moraxella strains, ...
|
|
|
Saponin adjuvant compositions
What is claimed is: 1. A Quillaja saponaria saponin composition for eliciting an immune response in an organism, comprising a combination of a substantially pure QS-7 ...
|
|
|
Quercetin derivatives and their medical usages
The invention claimed is: 1. A purified compound of formula I ##STR00002## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 are all or partly hydrogen atoms, or alkyl ...
|
|
|